你说奇怪不奇怪，2025年A股市场上，白酒和医药这对"难兄难弟"表现都挺让人挠头。 可就在大伙儿觉得这俩板块都蔫儿了的时候，医药公司的老板们却偷偷干了一件白酒老板们不太乐意干的事——砸重金回购自己家的股票，而且买回来就直 接"销毁"，再也不放出来了。 光是龙头就有38家参与了这场"烧钱游戏"，其中6家砸的钱超过5个亿，最狠的一家一下就是10个亿。 这可不是闹着玩的，这是真金白银往里扔，连眼睛都 不带眨的。 | 回购方案首次披露日 | 2025/8/21 | | --- | --- | | 回购方案实施期限 | 2025年8月20日~2026年8月19日 | | 预计回购全额 | 100,000万元~200,000万元 | | 回购用途 | □减少注册资本 | | | √用于员工持股计划或股权激励 □用于转换公司可转债 | | | □为维护公司价值及股东权益 | | 累计已回购股数 | 791.88万股 | | 累计已回购股数占总股本比例 | 0.12% STORE AND S | | 累计已回购金额 | 53,542.78万元 | 看看这阵仗，2025年整整一年，A股医药圈里就没消停过。 药明康德，行业里数一 ...

证券代码：600018 证券简称：上港集团 公告编号：2025-067 上海国际港务（集团）股份有限公司 关于总审计师离任的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 特此公告。 上海国际港务（集团）股份有限公司董事会 2025年12月26日 证券代码：600018 证券简称：上港集团 公告编号：2025-066 上海国际港务（集团）股份有限公司关于调整 上海国际港务（集团）股份有限公司（以下简称："公司"）董事会于2025年12月25日收到公司总审计师 杨海丰先生递交的书面辞职报告。杨海丰先生因工作调整原因申请辞去公司总审计师职务，辞职后将不 再担任公司任何职务。 一、离任的基本情况 ■ 二、离任对公司的影响 根据《中华人民共和国公司法》《公司章程》等有关规定，杨海丰先生的辞职报告自送达董事会之日起 生效，其离任不会影响公司相关工作的正常运行，相关工作已完成交接。截至本公告披露日，杨海丰先 生持有公司114,400 股股份，占公司总股本的0.00049%。杨海丰先生离任后将继续按照相关法律、法规 及规范性文件的规定 ...

截至2025年12月24日收盘，经纬恒润(688326)报收于113.76元，上涨2.16%，换手率3.34%，成交量3.73 万手，成交额4.3亿元。 当日关注点 交易信息汇总 资金流向 12月24日主力资金净流入2477.39万元；游资资金净流出950.06万元；散户资金净流出1527.33万元。 北京经纬恒润科技股份有限公司于2025年12月24日召开2025年第一次临时股东会，审议通过了关于回购 注销2023年限制性股票激励计划部分限制性股票的议案、变更注册资本、取消监事会、修改公司章程并 办理变更登记的议案、修订及制定公司部分治理制度的议案、使用公积金弥补亏损的议案。会议表决方 式符合法律法规及公司章程规定，所有议案均获通过，无被否决议案。北京观韬律师事务所对本次会议 进行了见证并出具法律意见书，认为会议召集、召开程序、出席人员资格、表决程序及结果合法有效。 北京观韬律师事务所关于北京经纬恒润科技股份有限公司2025年第一次临时股东会的法律意见书 北京经纬恒润科技股份有限公司于2025年12月24日召开2025年第一次临时股东会，会议由董事会召集， 董事长主持。会议审议通过了四项议案：回购注销202 ...

证券日报网讯12月18日，中国建筑在互动平台回答投资者提问时表示，公司市值表现受到市场偏好、行 业形势等多种因素影响，公司股价处于低估水平。2025年公司回购注销股票约8.87亿元，推动控股股东 增持股票金额约6.23亿元。公司自上市以来，连续16年坚持现金分红方式，且每股分红实现了逐年增 长，保持了现金分红的连续性、稳定性和可预期性。根据我国个人所得税法规定，个人投资者持有境内 上市公司股票超过1年的，其股息红利所得暂免征收个人所得税。 ...

Group 1 - The company is a leading player in the ophthalmology service sector with a market capitalization of over 100 billion [1] - There is a call from investors for the company to adopt a proactive approach similar to other successful companies by increasing share buybacks and management stock purchases to boost investor confidence [1] - The company’s secretary indicated that any future plans for buybacks or management purchases will be disclosed in accordance with regulations [1]

12月4日晚间，在消费板块估值修复预期升温的关键节点，老字号龙头东阿阿胶股份有限公司（以下简 称：东阿阿胶，股票代码：SZ000423）抛出重磅回馈方案。公司宣布近期启动1-2亿元股票回购计划， 所购股份将全部用于注销以增厚每股收益，叠加此前披露的分红方案，2025年以来东阿阿胶累计分红加 回购注销规模超过18亿元。作为连续多年坚持100%分红、累计分红超百亿的 "现金奶牛"，此次史无前 例的回购注销举措，不仅彰显公司对未来发展的坚定信心，更折射出消费白马股在业绩筑底、政策利好 共振下的价值潜力。 东阿阿胶的股东回馈传统堪称A股典范。数据显示，自上市以来，公司始终坚持高比例现金分红政策， 累计分红金额已超100亿元，分红比例连续多年保持100%，在消费行业乃至整个A股市场均属罕见。这 一坚持既体现了公司稳健的经营质地和充沛的现金流，更彰显了对股东利益的长期重视。 而此次推出的1-2亿元股票回购计划，标志着东阿阿胶在股东回报方式上的重大创新——这是公司上市 以来首次实施股份回购并注销。根据公告，回购股份将用于减少注册资本，此举直接作用于每股收益、 净资产收益率等核心财务指标的提升，通过优化资本结构实现股东价值的 ...

证券日报网讯 12月4日，新华医疗在互动平台回答投资者提问时表示，公司股票回购注销事宜需结合公 司未来经营规划、资金状况等多方面因素综合研判。后续若有相关安排，公司将严格按照信息披露规则 履行披露义务。 （编辑 姚尧） ...

Core Viewpoint - Qingdao Beer (600600) announced a stock repurchase and cancellation plan due to the resignation of an incentive plan participant, which triggered the conditions for repurchase and cancellation as per the plan's regulations [1] Group 1: Stock Repurchase Details - One incentive participant resigned for personal reasons, leading to a change in their status as an incentive object [1] - The company plans to repurchase and cancel a total of 1,667 restricted A-shares that were granted but not yet released from restrictions [1] - After this repurchase and cancellation, the remaining restricted A-shares will amount to zero [1] Group 2: Timeline and Future Actions - The cancellation of the shares is expected to be completed by November 13, 2025 [1]

Core Viewpoint - The consumption atmosphere is gradually warming up as the year-end approaches, with the "Double 11" shopping festival expected to be a competitive period, leading to a recovery in demand for high-end liquor, particularly for Feitian Moutai, which is seen as a market bellwether [1][5]. Group 1: Market Performance - The market for Feitian Moutai has shown a stable price trend across various regions, with slight regional price differences but overall stability reflecting a good cycle of demand recovery and sales [2][6]. - As of November 8, 2023, the price for 2025 Feitian Moutai in Tianjin is 1875 CNY per bottle for original packaging and 1820 CNY for loose bottles, while in Hubei, the prices are 1865 CNY and 1820 CNY respectively [2][3]. - In Jiangxi, the prices for 2025 Feitian Moutai are 1860 CNY for original packaging and 1820 CNY for loose bottles, indicating a consistent pricing strategy across the southern and northern markets [2][4]. Group 2: Sales Dynamics - Feedback from distributors indicates a smooth sales flow since October, with some reporting a year-on-year sales increase of 45%, driven by rising consumer demand during the "Double 11" promotional period [5][6]. - Consumers are returning to rational purchasing behaviors, focusing on needs rather than stockpiling, which has led to frequent purchases and a tight inventory situation in stores [6]. Group 3: Company Strategy and Market Position - Guizhou Moutai's management confirmed strong sales performance during a recent earnings call, noting a strategic reduction in supply from June to August to maintain market stability, which has resulted in a noticeable recovery in sales since August [7]. - The company reported a 7.26% year-on-year revenue increase for the third quarter, with a focus on maintaining a stable market presence and respecting market dynamics [7]. - International capital confidence in Moutai's long-term value is growing, as evidenced by the presence of 85 foreign institutional investors holding shares, with a market capitalization of 881.42 billion CNY [7]. Group 4: Industry Outlook - The liquor industry is returning to rational growth amidst various challenges, with price stabilization seen as a natural outcome in the long run [8]. - Moutai is actively building a positive cycle among enterprises, markets, and capital, which not only strengthens its foundation but also enhances the overall industry development [8].

Core Viewpoint - The company has completed the repurchase and cancellation of a portion of restricted stock under its 2023 stock option and restricted stock incentive plan, affecting a total of 18,200 shares [1] Summary by Sections Stock Repurchase and Cancellation - The repurchase and cancellation involved 18,200 shares of restricted stock that had not yet been released from restrictions, with the cancellation completed on October 30, 2025 [1] - Following the cancellation, the company's total share capital decreased from 224,657,333 shares to 224,639,133 shares [1] Share Structure Changes - The number of restricted shares with limited sale conditions decreased to 78,000 shares, while the number of unrestricted shares remained unchanged [1] - The company will proceed with the necessary business registration changes following the completion of the repurchase and cancellation [1]